128 related articles for article (PubMed ID: 2859018)
1. Somatostatin inhibits growth hormone-releasing factor-stimulated adenylate cyclase activity in GH, cells.
Reyl-Desmars F; Zeytin F
Biochem Biophys Res Commun; 1985 Mar; 127(3):986-91. PubMed ID: 2859018
[TBL] [Abstract][Full Text] [Related]
2. GRF is a highly potent activator of adenylate cyclase in the normal human, bovine and rat pituitary: interaction with somatostatin.
Reyl-Desmars F; Baird A; Zeytin FN
Biochem Biophys Res Commun; 1985 Mar; 127(3):977-85. PubMed ID: 2859017
[TBL] [Abstract][Full Text] [Related]
3. Somatocrinin stimulates adenylate cyclase-Ns regulatory subunit in a GH3 cell-line: comparison with VIP.
Reyl-Desmars F; Zeytin F; Lewin MJ
Peptides; 1986; 7 Suppl 1():165-7. PubMed ID: 2875442
[TBL] [Abstract][Full Text] [Related]
4. Actions of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary.
Harwood JP; Grewe C; Aguilera G
Mol Cell Endocrinol; 1984 Oct; 37(3):277-84. PubMed ID: 6149968
[TBL] [Abstract][Full Text] [Related]
5. Study of species specificity in growth hormone-releasing factor (GRF) interaction with vasoactive intestinal peptide (VIP) receptors using GRF and intestinal VIP receptors from rat and human: evidence that Ac-Tyr1hGRF is a competitive VIP antagonist in the rat.
Laburthe M; Couvineau A; Rouyer-Fessard C
Mol Pharmacol; 1986 Jan; 29(1):23-7. PubMed ID: 3003561
[TBL] [Abstract][Full Text] [Related]
6. Structural requirements for the activation of rat anterior pituitary adenylate cyclase by growth hormone-releasing factor (GRF): discovery of (N-Ac-Tyr1, D-Arg2)-GRF(1-29)-NH2 as a GRF antagonist on membranes.
Robberecht P; Coy DH; Waelbroeck M; Heiman ML; de Neef P; Camus JC; Christophe J
Endocrinology; 1985 Nov; 117(5):1759-64. PubMed ID: 2994998
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor.
Wood CL; O'Dorisio MS; Vassalo LM; Malarkey WB; O'Dorisio TM
Regul Pept; 1985 Nov; 12(3):237-48. PubMed ID: 3001842
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone-releasing factor-sensitive adenylate cyclase system of purified somatotrophs: effects of guanine nucleotides, somatostatin, calcium, and magnesium.
Narayanan N; Lussier B; French M; Moor B; Kraicer J
Endocrinology; 1989 Jan; 124(1):484-95. PubMed ID: 2562826
[TBL] [Abstract][Full Text] [Related]
9. Hormone-sensitive adenylate cyclase of prolactin-producing rat pituitary adenoma (GH4C1) cells: molecular organization.
Gordeladze JO; Sletholt K; Thorn NA; Gautvik KM
Eur J Biochem; 1988 Nov; 177(3):665-72. PubMed ID: 2904368
[TBL] [Abstract][Full Text] [Related]
10. Rat hypothalamic GRF elicits its biologic action in GH3 cells by interaction with VIP- preferring receptor site(s).
Zeytin FN; Reyl-Desmars F; Rathbun T
Biochem Biophys Res Commun; 1985 Mar; 127(3):992-8. PubMed ID: 2985067
[TBL] [Abstract][Full Text] [Related]
11. Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas.
Robberecht P; Waelbroeck M; Coy D; De Neef P; Camus JC; Christophe J
Peptides; 1986; 7 Suppl 1():53-9. PubMed ID: 3018703
[TBL] [Abstract][Full Text] [Related]
12. Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.
Waelbroeck M; Robberecht P; Coy DH; Camus JC; De Neef P; Christophe J
Endocrinology; 1985 Jun; 116(6):2643-9. PubMed ID: 2859987
[TBL] [Abstract][Full Text] [Related]
13. Secretion-stimulating and secretion-inhibiting hormones stimulate high-affinity pertussis-toxin-sensitive GTPases in membranes of a pituitary cell line.
Offermanns S; Schultz G; Rosenthal W
Eur J Biochem; 1989 Mar; 180(2):283-7. PubMed ID: 2564342
[TBL] [Abstract][Full Text] [Related]
14. Interaction of GRF with VIP receptors and stimulation of adenylate cyclase in rat and human intestinal epithelial membranes. Comparison with PHI and secretin.
Laburthe M; Amiranoff B; Boige N; Rouyer-Fessard C; Tatemoto K; Moroder L
FEBS Lett; 1983 Aug; 159(1-2):89-92. PubMed ID: 6307754
[TBL] [Abstract][Full Text] [Related]
15. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
16. Phorbol esters induce two distinct changes in GH3 pituitary cell adenylate cyclase activity.
Summers ST; Cronin MJ
Arch Biochem Biophys; 1988 Apr; 262(1):12-8. PubMed ID: 2833167
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin pretreatment desensitizes somatostatin receptors linked to adenylate cyclase and facilitates the stimulation of cyclic adenosine 3':5'-monophosphate accumulation in anterior pituitary tumor cells.
Reisine TD; Takahashi JS
J Neurosci; 1984 Mar; 4(3):812-9. PubMed ID: 6142935
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin inhibition of anterior pituitary adenylate cyclase activity: different sensitivity between male and female rats.
Schettini G; Florio T; Meucci O; Landolfi E; Lombardi G; Marino A
Brain Res; 1988 Jan; 439(1-2):322-9. PubMed ID: 2896042
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive intestinal peptide receptor antagonists in rat seminal vesicle membranes.
RodrÃguez-Pena MS; Guijarro LG; Prieto JC
Eur J Pharmacol; 1991 Nov; 208(3):207-12. PubMed ID: 1663044
[TBL] [Abstract][Full Text] [Related]
20. Human pancreatic tumor growth hormone-releasing factor stimulates anterior pituitary adenylate cyclase activity, adenosine 3',5'-monophosphate accumulation, and growth hormone release in a calmodulin-dependent manner.
Schettini G; Cronin MJ; Hewlett EL; Thorner MO; MacLeod RM
Endocrinology; 1984 Oct; 115(4):1308-14. PubMed ID: 6148231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
